Keyphrases
Polymorphism
100%
Survival Benefit
100%
Hepatocellular Carcinoma
100%
HSD17B13
100%
All-cause Mortality
20%
Hepatocellular Carcinoma Treatment
20%
Etiology
10%
Genetic Variants
10%
Kaplan-Meier
10%
Non-alcoholic Fatty Liver Disease (NAFLD)
10%
Liver Disease
10%
Multivariate Analysis
10%
Mortality Risk
10%
Genetic Polymorphism
10%
Disease-related
10%
Alcoholic Liver Disease
10%
Cox Regression
10%
Susceptibility Loci
10%
Genetic Factors
10%
Hepatocellular Carcinoma Surveillance
10%
United Kingdom Biobank
10%
Biobank Participants
10%
Transmembrane 6 Superfamily Member 2 (TM6SF2)
10%
Rs738409
10%
PNPLA3
10%
Rs58542926
10%
Curative Intent
10%
Susceptibility Variants
10%
Survival Estimation
10%
Wnt3a
10%
Genetic Susceptibility
10%
Therapeutic Inhibitors
10%
Baveno
10%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
100%
Genetic Polymorphism
50%
Multivariate Analysis
50%
Genetic Divergence
50%
Genetic Susceptibility
50%
Genetic Determinism
50%
PNPLA3
50%
WNT3A
50%
Immunology and Microbiology
All Cause Mortality
100%
Genetic Polymorphism
50%
Genetic Susceptibility
50%
Non-Alcoholic Fatty Liver Disease
50%
Heredity
50%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
All Cause Mortality
15%
Proportional Hazards Model
7%
Liver Disease
7%
Multivariate Analysis
7%
Cancer Diagnosis
7%
Heredity
7%
Alcohol-Related Liver Disease
7%
Nonalcoholic Fatty Liver
7%
Genetic Polymorphism
7%
PNPLA3
7%
Survival Estimate
7%
Genetic Susceptibility
7%